Request Demo
Last update 08 May 2025
Human Prothrombin Complex (Weiguang Biological Products)
Last update 08 May 2025
Overview
Basic Info
Drug Type Non-recombinant coagulation factor |
Synonyms- |
Action modulators |
Mechanism F10 modulators(Coagulation factor X modulators), factor IX modulators(Coagulation factor IX modulators), factor VII modulators(Coagulation factor VII modulators) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (21 May 2024), |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Human Prothrombin Complex (Weiguang Biological Products)CTR20180274
单臂、开放性、多中心临床试验评价人凝血酶原复合物治疗乙型血友病的安全性和有效性
[Translation] A single-arm, open-label, multicenter clinical trial to evaluate the safety and efficacy of human prothrombin complex therapy in the treatment of hemophilia B
100 Clinical Results associated with Human Prothrombin Complex (Weiguang Biological Products)
Login to view more data
100 Translational Medicine associated with Human Prothrombin Complex (Weiguang Biological Products)
Login to view more data
100 Patents (Medical) associated with Human Prothrombin Complex (Weiguang Biological Products)
Login to view more data
100 Deals associated with Human Prothrombin Complex (Weiguang Biological Products)
Login to view more data
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Hemophilia B | China | 21 May 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free